Effects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Jul 29

PMID 35903313

Authors

Shina Lee

Seung-Jung Kim

Affiliations

Soon will be listed here.

Abstract

Introduction: Endothelial dysfunction commonly occurs in chronic kidney disease (CKD) patients and increases the risk for cardiovascular disease. Among CKD patients, biomarkers involved in the pathogenesis of CKD-mineral bone disorder (CKD-MBD), such as phosphorus, parathyroid hormone, and fibroblast growth factor 23, are associated with endothelial dysfunction. We investigated whether these biomarkers induce endothelial dysfunction in CKD patients with normal phosphorus levels.

Methods: This cross-sectional study examined CKD patients with normal phosphorus levels; patients with an estimated glomerular filtration rate (eGFR) <15 or who were under dialysis were excluded. Iontophoresis with laser doppler flowmetry (ILDF) and peripheral arterial tonometry were performed to assess endothelial function in 85 patients. Pearson's correlation coefficient, multiple regression, and mediation analyses were performed to examine the association between CKD-MBD biomarkers and endothelial dysfunction.

Results: Endothelial dysfunction was observed in all subjects with a low response to ILDF and 27% of subjects according to peripheral arterial tonometry. Acetylcholine (Ach)-induced ILDF was significantly associated with eGFR ( = 0.22, = 0.04), intact parathyroid hormone (iPTH; = -0.46, < 0.01), and VCAM-1 ( = -0.36, < 0.01). The reactive hyperemia index (RHI) was significantly related to phosphorus levels ( = 0.32, < 0.01) and iPTH ( = -0.39, = 0.02). After adjusting for eGFR, iPTH and VCAM-1 remained independent factors for predicting endothelial dysfunction measured using Ach-induced ILDF. In addition, iPTH and phosphorus levels were independent predictors for endothelial dysfunction measured using RHI in the eGFR-adjusted model. Mediation analyses showed that the individual indirect effects of iPTH were significantly affected ILDF and RHI.

Conclusion: Serum levels of phosphorus and iPTH are associated with endothelial dysfunction, even in CKD patients with normal phosphorus levels.

Citing Articles

Association between Serum Phosphorus Levels and Diabetic Retinopathy: A Cross-Sectional Study.

Chen J, Liu C, Sun C, Zeng J, Chi J, Che K Int J Endocrinol. 2024; 2024:3830246.

PMID: 38904033 PMC: 11187971. DOI: 10.1155/2024/3830246.

References

Nohria A, Gerhard-Herman M, Creager M, Hurley S, Mitra D, Ganz P . Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985). 2006; 101(2):545-8. DOI: 10.1152/japplphysiol.01285.2005. View

Baylis C . Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol. 2006; 2(4):209-20. PMC: 2756810. DOI: 10.1038/ncpneph0143. View

Davis K, Ponnampalam J, Hayman R, Baker P, Arulkumaran S, Donnelly R . Microvascular vasodilator response to acetylcholine is increased in women with pre-eclampsia. BJOG. 2001; 108(6):610-4. DOI: 10.1111/j.1471-0528.2001.00144.x. View

Vaziri N, Ni Z, Wang X, Oveisi F, Zhou X . Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol. 1998; 274(4):F642-9. DOI: 10.1152/ajprenal.1998.274.4.F642. View

Saran R, Robinson B, Abbott K, Agodoa L, Bragg-Gresham J, Balkrishnan R . US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; 73(3 Suppl 1):A7-A8. PMC: 6620109. DOI: 10.1053/j.ajkd.2019.01.001. View

Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A . Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 1997; 52(1):171-81. DOI: 10.1038/ki.1997.317. View

Khan F, Elhadd T, Greene S, Belch J . Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care. 2000; 23(2):215-20. DOI: 10.2337/diacare.23.2.215. View

Morris S, Shore A, Tooke J . Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 1995; 38(11):1337-44. DOI: 10.1007/BF00401767. View

Kestenbaum B, Sampson J, Rudser K, Patterson D, Seliger S, Young B . Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2004; 16(2):520-8. DOI: 10.1681/ASN.2004070602. View

10.

Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8):2208-18. DOI: 10.1097/01.ASN.0000133041.27682.A2. View

11.

Houben A, Martens R, Stehouwer C . Assessing Microvascular Function in Humans from a Chronic Disease Perspective. J Am Soc Nephrol. 2017; 28(12):3461-3472. PMC: 5698072. DOI: 10.1681/ASN.2017020157. View

12.

Silswal N, Touchberry C, Daniel D, McCarthy D, Zhang S, Andresen J . FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Physiol Endocrinol Metab. 2014; 307(5):E426-36. PMC: 4154070. DOI: 10.1152/ajpendo.00264.2014. View

13.

Ryu J, Yu M, Lee S, Ryu D, Kim S, Kang D . AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis. Yonsei Med J. 2016; 57(4):942-9. PMC: 4951472. DOI: 10.3349/ymj.2016.57.4.942. View

14.

Perticone M, Maio R, Sciacqua A, Cimellaro A, Andreucci M, Tripepi G . Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients. Nutr Metab Cardiovasc Dis. 2016; 26(8):683-8. DOI: 10.1016/j.numecd.2016.02.003. View

15.

Wagner L, Riggleman A, Erdely A, Couser W, Baylis C . Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int. 2002; 62(2):532-6. PMC: 2747491. DOI: 10.1046/j.1523-1755.2002.00465.x. View

16.

Khan F, Patterson D, Belch J, Hirata K, Lang C . Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond). 2008; 115(9):295-300. DOI: 10.1042/CS20070431. View

17.

Block G, Levin N, Port F . Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998; 31(4):607-17. DOI: 10.1053/ajkd.1998.v31.pm9531176. View

18.

Yilmaz M, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E . FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int. 2010; 78(7):679-85. DOI: 10.1038/ki.2010.194. View

19.

Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastelein J . Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 1999; 19(5):1168-72. DOI: 10.1161/01.atv.19.5.1168. View

20.

Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M . Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009; 20(7):1504-12. PMC: 2709683. DOI: 10.1681/ASN.2008101106. View